FBRX

Forte Biosciences' stock has experienced several notable events in the past six months. The stock price increased by over 120% on a six-month basis and 265.21% over the last 12 months. In April 2026, the company announced a proposed public offering and priced a $150 million public offering, leading to a stock price increase. In March 2026, the company announced its 2025 results and provided an update, which was followed by a stock price decrease. Forte also reported inducement grants under Nasdaq Listing Rules on March 4 and March 17, 2026, with stock price changes of -4.66% and -6.01% respectively. In February 2026, Forte Biosciences announced plans to present at upcoming investor meetings, resulting in a stock price change. In January 2026, the company's market cap fell and a new major risk related to share price stability was identified, noting the stock's high volatility.